TrialCancer immunology, immunotherapy : CII2005
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma.
Peter Hersey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it